Michael Pohl
Impact in
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 13
- Colorectal Cancer Treatments and Studies 8
- HER2/EGFR in Cancer Research 5
-
- Gastric Cancer Management and Outcomes 7
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Wolff Schmiegel (9 shared papers)Ulrike John (7 shared papers)Tomáš Seeman (5 shared papers)Andrea Tannapfel (10 shared papers)Anke Reinacher‐Schick (4 shared papers)Roland Schroers (4 shared papers)Ullrich Graeven (3 shared papers)Peter Thuss‐Patience (4 shared papers)
- Journals
- Pediatric Nephrology (3 papers)European Journal of Cancer (3 papers)International Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)Kidney & Blood Pressure Research (2 papers)
- Partner nations
- GermanyUnited StatesCzechia
In The Last Decade
Michael Pohl
47 papers receiving 808 citations
Peers
Comparison fields: 5 of 75
- Gastroenterology 54
- Oncology 261
- Pulmonary and Respiratory Medicine 218
- Cancer Research 99
- Pathology and Forensic Medicine 91
Countries citing papers authored by Michael Pohl
This map shows the geographic impact of Michael Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Pohl more than expected).
Fields of papers citing papers by Michael Pohl
This network shows the impact of papers produced by Michael Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Pohl. The network helps show where Michael Pohl may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Pohl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 63 | |
| 2 | 2013 | 53 | |
| 3 | 2015 | 52 | |
| 4 | 2006 | 50 | |
| 5 | 2011 | 49 | |
| 6 | 2022 | 47 | |
| 7 | 2014 | 41 | |
| 8 | 2020 | 38 | |
| 9 | SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells. | 2010 | 36 |
| 10 | 2018 | 35 | |
| 11 | 2011 | 33 | |
| 12 | 2008 | 28 | |
| 13 | 2011 | 27 | |
| 14 | 1997 | 27 | |
| 15 | 2009 | 26 | |
| 16 | 2005 | 23 | |
| 17 | 2015 | 21 | |
| 18 | 2009 | 19 | |
| 19 | 2016 | 19 | |
| 20 | 2009 | 18 |
About Michael Pohl
Michael Pohl is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 50 papers that have together received 842 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (7 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (4 papers), Blood Pressure and Hypertension Studies (3 papers), Pediatric Urology and Nephrology Studies (3 papers) and Sodium Intake and Health (2 papers). The work is most often cited by research in Gastroenterology (54 citations), Oncology (261 citations), Pulmonary and Respiratory Medicine (218 citations), Cancer Research (99 citations) and Pathology and Forensic Medicine (91 citations). Michael Pohl has collaborated with scholars based in Germany, United States and Czechia. Frequent co-authors include Wolff Schmiegel, Ulrike John, Tomáš Seeman, Andrea Tannapfel, Anke Reinacher‐Schick, Roland Schroers, Ullrich Graeven, Peter Thuss‐Patience, Susanne Klein‐Scory and Alexander Baraniskin. Their work appears in journals such as Pediatric Nephrology, European Journal of Cancer, International Journal of Cancer, Journal of Clinical Oncology and Kidney & Blood Pressure Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.